Thermo Fisher Scientific Expands in Asia-Pacific Markets

By combining with Thermo Fisher, Lomb Scientific believes that its customers will have access to an even greater range of products at competitive prices and service.

Thermo Fisher CEO and President Marc Casper said that the purchase is part of the company's goal to "expand in growing Asia-Pacific markets."

Lomb Scientific serves as a supplier to healthcare markets including hospitals, universities, research, and analytical labs in Australia and New Zealand, as well as in parts of Asia and the Middle East.

Jeremy Samuel, managing director from Anacacia Capital (Double Bay, Australia) who led the Lomb Scientific investment said, "Anacacia Capital has enjoyed working with Lomb Scientific's team to strengthen the business to be a leader in the science field. The transaction represents an outstanding opportunity.” Anacacia Capital is a leading Australian private equity firm that invests in small to medium enterprises (SMEs) looking to raise capital.

Thermo Fisher Scientific serves customers within pharmaceutical and biotech companies, hospitals, and clinical diagnostic labs, universities, research institutions, and government agencies, as well as in environmental and process control industries. Its two major brands are Thermo Scientific and Fisher Scientific.

Related Links
Thermo Fisher Scientific
Lomb Scientific
Anacacia Capital